Th17 cells: Interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease

  • Raza A
  • Yousaf W
  • Giannella R
 et al. 
  • 52


    Mendeley users who have this article in their library.
  • 39


    Citations of this article.


Inflammatory bowel disease (IBD) is a chronic inflammatory state of the GI tract of unknown etiology. Classically, tissue injury in IBD is thought to be primarily mediated by Th1 cells in Crohn's disease or Th2 cells in ulcerative colitis. The discoveries of new subsets of T-helper cells, especially Th17 cells, have revolutionized our understanding of the disease immunopathology. Th17 cells seem to affect both innate and adaptive immune responses by the release of regulatory cytokines. Understanding the role of Th17 cells in IBD pathogenesis and targeting their regulatory cytokines may provide potential therapeutic approaches for the treatment of IBD in the future.

Author-supplied keywords

  • CD
  • Crohns disease
  • T-helper cells
  • Th17
  • UC
  • inflammatory bowel disease
  • interleukin-17
  • ulcerative colitis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Ali Raza

  • Wajeeha Yousaf

  • Ralph Giannella

  • Mohamed Tarek Shata

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free